Search for: "Price v. Illinois" Results 541 - 560 of 935
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 May 2007, 10:40 am
Bayer Corp., 398 F.3d 640, 643 (7th Cir. 2005) (applying Illinois law); Thomas v. [read post]
3 Aug 2020, 10:40 am by Jeremy T. Rosenblum and James Kim
”  This attempt to dismiss pricing impacts as insignificant simply doesn’t hold water. [read post]
15 Apr 2011, 6:02 am by Bexis
App. 1980) (barring recovery of damages for personal injury under HRS chapter 480).Nuff said.IdahoWe see nothing.IllinoisOnly “actual economic damages” may be awarded under the Illinois statute. [read post]
24 May 2012, 6:51 am
The possibility of investing in FB's initial public offering, as in any other IPO, always bore the risk of buying an IPO at a price above its market price-that is the price it has in the publicly traded market. [read post]
11 May 2011, 4:54 am by Marie Louise
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty: Lundbeck… [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
23 Dec 2009, 5:28 am by Susan Brenner
Illinois, 359 U.S. 121, 123-124 (1959), the U.S. [read post]
1 Apr 2019, 5:00 am by John Jascob
The argument that the spoof orders could not be fraudulent because they were executable and subject to market risk was rejected in the Seventh Circuit’s landmark decision in U.S. v. [read post]
31 Aug 2010, 10:01 pm by Kelly
(Spicy IP) India: NPPA proposes controlling the price of cancer drugs (Spicy IP) India: Requiem for a dream? [read post]
2 Sep 2010, 6:43 am by Mala Mason
The Court of Appeals for one district in Ohio recently approved such a sale in Park National Bank v. [read post]
7 Jun 2013, 8:43 am by Sheppard Mullin
Fortunately, the Delaware Chancery Court recently issued a decision, entitled Edgewater Growth Capital Partners, L.P. v. [read post]